Press Releases
-
BOC Sciences Unveils Comprehensive Capabilities of Custom Peptide Drug Conjugate
BOC Sciences unveils its comprehensive capabilities of custom peptide drug conjugate from project design to commercial production.
May 7, 2023
-
Functional Diamonds: Unlocking Possibilities in Various Fields
-
PEGS Week 2023: Creative Biolabs Unveils the Agenda
Creative Biolabs is ready for the PEGS Boston Summit, which will exhibit at booth 205 from May 15–19.
May 13, 2023
-
Thermo Fisher Scientific Expands ImmunoCAP™ Test Availability Across U.S.
Thermo Fisher Scientific today announced its expansion of ImmunoCAP™ Specific IgE test availability to more patients across the U.S. through all Kroger Health The Little Clinic locations.
May 10, 2023
-
Amerigo Scientific Unveils 1Step RT PCR Kit to Support RNA Studies and Simply Workflow
Amerigo Scientific unveils 1Step RT PCR Kit for the scientific use of gene-expression analysis, transfection analysis, cDNA cloning, multiplex RT-PCR, etc.
May 7, 2023
-
CureSearch to fund new study for aggressive pediatric bone cancer
Although overall survival rates for childhood osteosarcoma are improving, there have been no significant improvements in survival outcomes for patients with metastasis. CureSearch is funding a novel study that may highly impact the survival of osteosarcoma patients by uncovering new clinical opportunities for treatment.
May 7, 2023
-
Exothera Nucleic Acids Strengthens Team with Industry Expert
Exothera Nucleic Acids has announced the appointment of Dr. Patrick Thiaville as Chief Technology Officer to support its growth in the rapidly expanding RNA therapies market.
May 8, 2023
-
CD Formulation Unveils Its Latest Offering: A Comprehensive Line of Pharmaceutical Formulation Characterization Testing Services
-
Huateng Pharma Develops CDK4/6 Inhibitors Against Breast Cancer
-
Biopharma PEG Supplies PEG Products For Lipid Nanoparticles (LNPs)
-
Paradigm Clinical Research Announces Expansion of Site Locations
-
FDA Clears New Laboratory Blood Glucose Reference Analyzer from Nova Biomedical
The U.S. FDA has cleared Nova Primary™ as a blood glucose reference analyzer for manufacturers of blood glucose measuring devices and clinical researchers. Nova Primary fills the need for a new glucose reference analyzer to replace the discontinued YSI STAT PLUS 2300 Glucose and L-Lactate analyzer (YSI, Inc., Yellow Springs, OH).
Oct 27, 2022
-
Exothera announces a strategic partnership with Quantoom Biosciences and launches a new business unit for the development and production of RNA
Exothera has partnered with Quantoom Biosciences to gain access to Quantoom’s Nfinity technology, a continuous production platform for RNA.
Apr 25, 2023
-
New Lonza Webinar — “Taking the Leap into an MES from a CEO’s Perspective”
On May 4, 2023, Lonza Bioscience Informatics will present a free 45-minute webinar that includes a discussion with Dr Phanesh Koneru, CEO, Exela® Pharma Sciences.
Apr 26, 2023
-
Onyx Scientific increases non-GMP capabilities with CMC facility expansion
-
BullFrog AI Partners with the Sage Group to Explore JV Opportunities to Advance its Oncology Assets
-
AARDEX Group Partners with Industry Leaders on DiMe’s V3+ Framework Project to Enhance Usability of DHTs
AARDEX Group Partners with Industry Leaders on DiMe’s V3+ Framework Project to Enhance Usability of DHTs Extending the Verification, Analytical Validation, and Clinical Validation (V3+) Framework Project will ensure digital clinical measures and products meet the needs of larger audiences.
May 2, 2023
-
Elligo Health Research Opens New, Larger Clinical Research Center in Austin
Elligo Health Research®, the largest healthcare-enabling research organization, has opened its new clinical research center in Austin, Texas.
May 1, 2023
-
CluePoints Supports Launch of RBQM Live 2023 as Premier Event Sponsor
CluePoints Supports Launch of RBQM Live 2023 as Premier Event Sponsor Registration for must-attend Risk-Based Quality Management event is now open
May 2, 2023
-
Arranta Bio, a Recipharm company, signs contract with MIT to develop rapid manufacturing of mRNA therapeutics